LLY · 8-K · 20260805PR000077

Manufacturing Investment - Indiana

ELI LILLY & Co · 2026-08-05 · Importance 52 · Surprise 42

Lilly committed an additional $4.5 billion to expand manufacturing sites in Indiana. The program includes opening the company's first dedicated genetic medicine facility. The investment is intended to add capacity alongside the planned launch of next-generation products, including retatrutide.